Neovascularization: Clinical Trials

1 trial for Neovascularization, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow Neovascularization: new trials by email Literature Review of Neovascularization trials Research Report on Neovascularization

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
ziv-aflibercept - Neovascularization, Macular Degeneration
Phase 2UnknownRafic Hariri University Hospital1002015-03-012018-08-29

Narrower conditions

Choroidal Neovascularization (1)  ·  Diabetic Retinopathy (1)  ·  Macular Degeneration (1)  ·  Macular Edema (1)  ·  Neovascularization, Pathologic (1)  ·  Pterygium (1)  ·  Retinal Neovascularization (1)  ·  Retinal Vein Occlusion (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Choroid Diseases (1)  ·  Conjunctival Diseases (1)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Diabetic Angiopathies (1)  ·  Embolism and Thrombosis (1)  ·  Endocrine System Diseases (1)  ·  Eye Diseases (1)  ·  Metaplasia (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Retinal Degeneration (1)  ·  Retinal Diseases (1)  ·  Thrombosis (1)

Interventions

aflibercept (1)

Sponsors

Rafic Hariri University Hospital (1)

Countries

Lebanon (1)

Top investigators

Ahmad M Mansour, MD (1)

Results publications

PMID 25677668, PMID 27030277, PMID 28614154, PMID 31956432